Too Much Too Soon? Eurasian Medtech Reg Framework Speeds ahead But Russian Concerns Persist
This article was originally published in Clinica
Executive Summary
The Eurasian Economic Commission has moved fast in developing a common market framework for medical devices and medicines for its Eurasian member states – too fast, in the view of IMEDA, Russia’s International Medical Device Manufacturers Association, which fears that quality may have been sacrificed in the drive to meet the 2015 year-end deadline
You may also be interested in...
Medtechs Must Forearm For Russia’s Tough Market-Access Pathway
Russia has the most complex medical device registration process in the world – that's the claim of one senior medtech regulatory expert speaking at a recent Informa Life Sciences conference. Local knowledge and local partners will be key elements for those companies wishing to succeed in Russia.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.